Pages • 2
Merck & Company: Evaluating A Drug Licensing Opportunity Essay Preview: Merck & Company: Evaluating A Drug Licensing Opportunity Report this essay Should Merck license the compound? Merck would be responsible for 1) the approval of Davanrik 2) the manufacture of Danavrik 3) marketing of Danavrik Merck would pay LAB for 1) initial fee 2) royalty.